Alzheimer – Aging-news

Research & Science EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer’s Prevention Trials

At a meeting of the EU/US/Clinical Trials in Alzheimer’s Disease (CTAD) Task Force in December 2016, an international group of investigators from industry, academia, and regulatory agencies reviewed lessons learned from ongoing and planned prevention trials, which will help guide… Continue Reading →

News The 2018 Revised FDA Guidance for Early Alzheimer’s Disease: Establishing the Meaningfulness of Treatment Effects

The present report reviews the revised 2018 FDA guidance for early AD, with an emphasis on meaningfulness of clinical outcome assessments (COAs). A radical shift is evident in the importance given to establishing the meaningfulness of COAs in the 2018… Continue Reading →

News Implementing a memory clinic model to facilitate recruitment into early phase clinical trials for mild cognitive impairment and alzheimer’s disease

Our objective was to significantly facilitate recruitment into AD clinical trials by providing resources and education to patients, their treating physicians, and caregivers in the community. Park, C. Kouhanim, S. Lee, Z. Mendoza, K. Patrick, L. Gertsik, C. Aguilar, D…. Continue Reading →

Alzheimer • Research & Science

Research & Science EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer’s Prevention Trials

News The 2018 Revised FDA Guidance for Early Alzheimer’s Disease: Establishing the Meaningfulness of Treatment Effects

News Implementing a memory clinic model to facilitate recruitment into early phase clinical trials for mild cognitive impairment and alzheimer’s disease

Recent Posts

Slider